Regeneron Genetics Center (RGC) will join the alliance, while GSK and Amgen will help integrate the proteomic data. ebx.sh/uFZdBm
07.03.2026 07:41
👍 2
🔁 0
💬 0
📌 0
Regeneron Genetics Center (RGC) will join the alliance, while GSK and Amgen will help integrate the proteomic data. ebx.sh/uFZdBm
The group has already helped pass bills in Arkansas and Oklahoma, and is supporting bills introduced in Florida, Mississippi, and Tennessee. ebx.sh/jUmPpI
Investigators at CHOP and UPenn found that lower cell counts could still be associated with poor outcomes if the cells were poorly differentiated.
Researchers found proteins with significant shifts in ME/CFS patients, pointing to multiple tissue- and immune system-related changes. ebx.sh/3WmMHe
A machine learning-based classifier outperformed standard methods for identifying early liver disease and distinguishing it from other conditions. ebx.sh/KAF03Z
CRISPR Functional Genomics Approach Helps Untangle AML Targets, Resistance
CMS Request Indicates Interest in Broadening Use of MolDX to Combat Genetic Testing Fraud
Promising $150 Genome, Roche Reveals More Details of Axelios Sequencer at AGBT
VA Wants to Make it Easier for Primary Care Docs to ID Men at Risk of Prostate Cancer
Laboratory, Diagnostics, Tools Firms Top $32M in Washington D.C. Lobbying in 2025
Complete Genomics to Shed Chinese Ownership Through Acquisition by Swiss Rockets
As Hype Fades, Single-Molecule Proteomics Firms Work to Carve out Commercial Niches
Cat Cancer Genomes Point to Driver Genes, Similarities to Human Disease
Minneapolis Genetics Professionals Speak Out on Public Health Harms of ICE Crackdown
NYC Medical Examiner's Office Expands Molecular Autopsy Program as Public Health Policy
Anxiety Disorder Genetic Risk Variants Identified in Large-Scale GWAS
Four-Biomarker Blood Test Could Improve Early Pancreatic Cancer Detection
Four-Gene Blood Biomarker Test Could Improve Early Pancreatic Cancer Detection
Genetic Testing Driving Increase in Medicare Lab Spending, According to HHS OIG Report
Legal Ruling on FDA Authority Over LDTs Raises Questions for Advanced Dx, CDx Developers
Circulating Tumor Cell Assay Finds Best Responders to Amgen's Small Cell Lung Cancer Drug
Mira Precision Health Enters US DPYD Testing Market With Expanded Assay for Chemo Risks
Pathway to Medicare Coverage for MCED Tests Included in Federal Spending Package
Advanced Diagnostics Space Poised to Alter Broader Dx, Tools Landscape
Foli Bio Turns to Exfoliated Fecal RNA To Develop Gut Disease Diagnostics
